prochlorperazine edisylate

Generic: prochlorperazine edisylate

Labeler: baxter healthcare corporation
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name prochlorperazine edisylate
Generic Name prochlorperazine edisylate
Labeler baxter healthcare corporation
Dosage Form INJECTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

prochlorperazine edisylate 5 mg/mL

Manufacturer
Baxter Healthcare Corporation

Identifiers & Regulatory

Product NDC 43066-090
Product ID 43066-090_5894a965-dd6b-4435-b2e5-203a23d4b70e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214379
Listing Expiration 2026-12-31
Marketing Start 2021-05-03

Pharmacologic Class

Classes
phenothiazine [epc] phenothiazines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43066090
Hyphenated Format 43066-090

Supplemental Identifiers

RxCUI
2102949
UPC
0343066090012
UNII
PG20W5VQZS

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name prochlorperazine edisylate (source: ndc)
Generic Name prochlorperazine edisylate (source: ndc)
Application Number ANDA214379 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 5 mg/mL
source: ndc
Packaging
  • 25 VIAL in 1 CARTON (43066-090-25) / 2 mL in 1 VIAL (43066-090-01)
source: ndc

Packages (1)

Ingredients (1)

prochlorperazine edisylate (5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "5894a965-dd6b-4435-b2e5-203a23d4b70e", "openfda": {"upc": ["0343066090012"], "unii": ["PG20W5VQZS"], "rxcui": ["2102949"], "spl_set_id": ["11cb37c7-01b4-4223-b2ea-a3695639b80b"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (43066-090-25)  / 2 mL in 1 VIAL (43066-090-01)", "package_ndc": "43066-090-25", "marketing_start_date": "20210503"}], "brand_name": "PROCHLORPERAZINE EDISYLATE", "product_id": "43066-090_5894a965-dd6b-4435-b2e5-203a23d4b70e", "dosage_form": "INJECTION", "pharm_class": ["Phenothiazine [EPC]", "Phenothiazines [CS]"], "product_ndc": "43066-090", "generic_name": "prochlorperazine edisylate", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PROCHLORPERAZINE EDISYLATE", "active_ingredients": [{"name": "PROCHLORPERAZINE EDISYLATE", "strength": "5 mg/mL"}], "application_number": "ANDA214379", "marketing_category": "ANDA", "marketing_start_date": "20210503", "listing_expiration_date": "20261231"}